UChicago Medicine Faculty Physicians
Abhinav Sidana, MBBS
Abhinav Sidana, MBBS
UChicago Medicine Faculty Physicians
Associate Professor of Surgery
Director, Prostate Cancer Focal Therapy
Co-Director, High Risk and Advanced Prostate Cancer Clinic
Specialties
- Urology
- Urologic Oncology (Urologic Cancer)
Locations
- Chicago - Hyde Park
- Tinley Park
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Abhinav Sidana, MBBS, MPH, is a urologic oncologist who specializes in prostate and kidney cancer, performing both robotic and open surgery for patients diagnosed with urologic cancers.
As director of the focal therapy program team, Dr. Sidana’s goal centers around providing organ-preserving treatment, with lower side effects, for prostate cancer. He has extensive experience with cryoablation, high-intensity focused ultrasound ablation (HIFU), TULSA Pro, and irreversible electroporation (IRE) of the prostate. In addition, Dr Sidana also offers robotic prostatectomy for patients with more aggressive prostate cancer, as well as performs open and robotic surgery for patients with complex, multifocal and advanced kidney cancers.
Along with his dedication to his clinical practice, Dr. Sidana is actively involved in urologic cancer research. He is investigating functional prostate imaging, image-guided and focal treatments for prostate cancer as well as clinical trials on novel treatments for urologic cancers. Dr. Sidana has been the principal investigator of several interventional clinical trials in prostate cancer and has published more than 100 peer-reviewed articles and book chapters. He also offers physician training and directs training courses for physicians in transperineal prostate biopsy techniques and focal therapy for prostate cancer.
As director of the focal therapy program team, Dr. Sidana’s goal centers around providing organ-preserving treatment, with lower side effects, for prostate cancer. He has extensive experience with cryoablation, high-intensity focused ultrasound ablation (HIFU), TULSA Pro, and irreversible electroporation (IRE) of the prostate. In addition, Dr Sidana also offers robotic prostatectomy for patients with more aggressive prostate cancer, as well as performs open and robotic surgery for patients with complex, multifocal and advanced kidney cancers.
Along with his dedication to his clinical practice, Dr. Sidana is actively involved in urologic cancer research. He is investigating functional prostate imaging, image-guided and focal treatments for prostate cancer as well as clinical trials on novel treatments for urologic cancers. Dr. Sidana has been the principal investigator of several interventional clinical trials in prostate cancer and has published more than 100 peer-reviewed articles and book chapters. He also offers physician training and directs training courses for physicians in transperineal prostate biopsy techniques and focal therapy for prostate cancer.
Specialties
Areas of Expertise
- Prostate Cancer
- Kidney Cancer
- Minimally Invasive & Robotic Urologic Surgery
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Urology
Languages Spoken
- English
Medical Education
- All India Institute of Medical Sciences
Internship
- University of Cinncinnati College of Medicine
Residency
- University of Cincinnati College of Medicine
Fellowship
- National Cancer Institute
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
*Click Here to visit our insurance page and learn more.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.